232
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy of phospholipidated curcumin in nonalcoholic fatty liver disease: a clinical study

, , , &
Pages 798-805 | Received 14 Sep 2016, Accepted 24 Jul 2018, Published online: 11 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Dina A. Hafez, Kadria A. Elkhodairy, Mohamed Teleb & Ahmed O. Elzoghby. (2020) Nanomedicine-based approaches for improved delivery of phyto-therapeutics for cancer therapy. Expert Opinion on Drug Delivery 17:3, pages 279-285.
Read now
Ajaikumar B. Kunnumakkara, Choudhary Harsha, Kishore Banik, Rajesh Vikkurthi, Bethsebie L. Sailo, Devivasha Bordoloi, Subash C. Gupta & Bharat B. Aggarwal. (2019) Is curcumin bioavailability a problem in humans: lessons from clinical trials. Expert Opinion on Drug Metabolism & Toxicology 15:9, pages 705-733.
Read now

Articles from other publishers (15)

Zhishen Jiang, Liu Liu, Hengpei Su, Yubin Cao, Zhongkai Ma, Yujie Gao & Dingming Huang. (2024) Curcumin and analogues in mitigating liver injury and disease consequences: From molecular mechanisms to clinical perspectives. Phytomedicine 123, pages 155234.
Crossref
Priyanka Joshi, Akansha Bisht, Ajita Paliwal, Jaya Dwivedi & Swapnil Sharma. (2023) Recent updates on clinical developments of curcumin and its derivatives. Phytotherapy Research 37:11, pages 5109-5158.
Crossref
Yuting Luo, Yujiao Zeng, Jiayan Peng, Kun Zhang, Lijie Wang, Tu Feng, Tsedien Nhamdriel & Gang Fan. (2023) Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies. Biomedicine & Pharmacotherapy 165, pages 115274.
Crossref
Ajaikumar B. Kunnumakkara, Mangala Hegde, Dey Parama, Sosmitha Girisa, Aviral Kumar, Uzini Devi Daimary, Prachi Garodia, Sarat Chandra Yenisetti, Oommen V. Oommen & Bharat B. Aggarwal. (2023) Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials. ACS Pharmacology & Translational Science 6:4, pages 447-518.
Crossref
Mangala Hegde, Sosmitha Girisa, Bandari BharathwajChetty, Ravichandran Vishwa & Ajaikumar B. Kunnumakkara. (2023) Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?. ACS Omega 8:12, pages 10713-10746.
Crossref
Timothy M. Panknin, Carol L. Howe, Meg Hauer, Bhanu Bucchireddigari, Anthony M. Rossi & Janet L. Funk. (2023) Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials. International Journal of Molecular Sciences 24:5, pages 4476.
Crossref
Yujiao Zeng, Yuting Luo, Lijie Wang, Kun Zhang, Jiayan Peng & Gang Fan. (2023) Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies. International Journal of Molecular Sciences 24:4, pages 3323.
Crossref
Pernille H. Hellmann, Jonatan I. Bagger, Katrine R. Carlander, Julie Forman, Elizaveta Chabanova, Jens S. Svenningsen, Jens J. Holst, Matthew P. Gillum, Tina Vilsbøll & Filip K. Knop. (2022) The effect of curcumin on hepatic fat content in individuals with obesity. Diabetes, Obesity and Metabolism 24:11, pages 2192-2202.
Crossref
Aya Yaseen Mahmood AlabdaliSasikala ChinnappanBasma M. Abd RazikMogana RShaik Ibrahim KhalivullaRahman H. (2022) Pharmacological activities of Curcumin: An update. Research Journal of Pharmacy and Technology, pages 2809-2813.
Crossref
Rou Tang, Rui Li, He Li, Xiao-Lei Ma, Peng Du, Xiao-You Yu, Ling Ren, Lu-Lu Wang & Wen-Sheng Zheng. (2021) Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease. ACS Nano 15:11, pages 17016-17046.
Crossref
Gracjan Różański, Sławomir Kujawski, Julia L. Newton, Paweł Zalewski & Joanna Słomko. (2021) Curcumin and Biochemical Parameters in Metabolic-Associated Fatty Liver Disease (MAFLD)—A Review. Nutrients 13:8, pages 2654.
Crossref
Hang-Yu Li, Ren-You Gan, Ao Shang, Qian-Qian Mao, Quan-Cai Sun, Ding-Tao Wu, Fang Geng, Xiao-Qin He & Hua-Bin Li. (2021) Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application. Oxidative Medicine and Cellular Longevity 2021, pages 1-23.
Crossref
Magisetty Obulesu. 2021. Turmeric and Curcumin for Neurodegenerative Diseases. Turmeric and Curcumin for Neurodegenerative Diseases 123 137 .
Yunes Panahi, Ashraf Karbasi, Ghasem Valizadegan, Nayyereh Ostadzadeh, Sara Saffar Soflaei, Tannaz Jamialahmadi, Muhammed Majeed & Amirhossein Sahebkar. 2021. Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health. Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health 119 126 .
Maryam Saberi-Karimian, Mahtab Keshvari, Majid Ghayour-Mobarhan, Leila Salehizadeh, Sepideh Rahmani, Behzad Behnam, Tannaz Jamialahmadi, Sedigheh Asgary & Amirhossein Sahebkar. (2020) Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Complementary Therapies in Medicine 49, pages 102322.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.